Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers.
Meaume S, Truchetet F, Cambazard F, Lok C, Debure C, Dalac S, Lazareth I, Sigal ML, Sauvadet A, Bohbot S, Dompmartin A; CHALLENGE Study Group. Meaume S, et al. Among authors: sauvadet a. Wound Repair Regen. 2012 Jul-Aug;20(4):500-11. doi: 10.1111/j.1524-475X.2012.00797.x. Epub 2012 Jun 8. Wound Repair Regen. 2012. PMID: 22681551 Clinical Trial.
Efficacy of two compression systems in the management of VLUs: results of a European RCT.
Lazareth I, Moffatt C, Dissemond J, Lesne Padieu AS, Truchetet F, Beissert S, Wicks G, Tilbe H, Sauvadet A, Bohbot S, Meaume S. Lazareth I, et al. Among authors: sauvadet a. J Wound Care. 2012 Nov;21(11):553-4, 556, 558 passim. doi: 10.12968/jowc.2012.21.11.553. J Wound Care. 2012. PMID: 23413494 Clinical Trial.
DECLARATION OF INTEREST: This study was sponsored by a grant from Laboratoires URGO, manufacturers of KTwo. S. Bohbot and A. Sauvadet are employees of Laboratoires Urgo. S. Meaume has received monetary compensation as a speaker for Laboratoires Urgo. . …
DECLARATION OF INTEREST: This study was sponsored by a grant from Laboratoires URGO, manufacturers of KTwo. S. Bohbot and A. …
Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial.
Edmonds M, Lázaro-Martínez JL, Alfayate-García JM, Martini J, Petit JM, Rayman G, Lobmann R, Uccioli L, Sauvadet A, Bohbot S, Kerihuel JC, Piaggesi A. Edmonds M, et al. Among authors: sauvadet a. Lancet Diabetes Endocrinol. 2018 Mar;6(3):186-196. doi: 10.1016/S2213-8587(17)30438-2. Epub 2017 Dec 20. Lancet Diabetes Endocrinol. 2018. PMID: 29275068 Clinical Trial.
Optimizing wound care with a new lipido-colloid dressing (Urgotul Duo).
Meaume S, Ourabah Z, Charru P, Meyer P, Perez J, Sauvadet A, Bohbot S. Meaume S, et al. Among authors: sauvadet a. Br J Nurs. 2007 Mar 22-Apr 11;16(6):S4, S6, S8 passim. doi: 10.12968/bjon.2007.16.Sup1.27088. Br J Nurs. 2007. PMID: 17505400 Clinical Trial.
Management of diabetic foot ulcers with a TLC-NOSF wound dressing.
Richard JL, Martini J, Bonello Faraill MM, Bemba JM, Lepeut M, Truchetet F, Ehrler S, Schuldiner S, Sauvadet A, Bohbot S. Richard JL, et al. Among authors: sauvadet a. J Wound Care. 2012 Mar;21(3):142-7. doi: 10.12968/jowc.2012.21.3.142. J Wound Care. 2012. PMID: 22399083
Leg ulcers and the Urgocell Non-Adhesive wound dressing.
Fays S, Schmutz JL, Vin F, Thirion V, Sigal-Grinberg M, Ingen-Housz-Oro S, Esteve E, Sauvadet A, Bohbot S. Fays S, et al. Among authors: sauvadet a. Br J Nurs. 2005 Jun 9-22;14(11):S15-20. doi: 10.12968/bjon.2005.14.Sup2.18211. Br J Nurs. 2005. PMID: 15976606 Clinical Trial.
32 results